These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 35822950)

  • 1. Efficacy of an Anti-Semaphorin 3A Neutralizing Antibody in a Male Experimental Retinal Vein Occlusion Mouse Model.
    Nakamura S; Nishinaka A; Hidaka Y; Shimazawa M; Thomas L; Bakker RA; Hara H
    Invest Ophthalmol Vis Sci; 2022 Jul; 63(8):14. PubMed ID: 35822950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aqueous semaphorin 3A level correlates with retinal macular oedema and ganglion cell degeneration in patients with retinal vein occlusion.
    Guo S; Ren J; Li Z; Fan X; Qin L; Li J
    Acta Ophthalmol; 2019 May; 97(3):273-278. PubMed ID: 30803163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BI-Y, an Neuropilin-1 Antagonist, Enhances Revascularization and Prevents Vascular Endothelial Growth Factor-A Induced Retinal Hyperpermeability in Rodent Models of Retinopathies.
    Thomas L; Low S; Hansen G; Bakker RA; Zippel N
    J Pharmacol Exp Ther; 2023 Jun; 385(3):214-221. PubMed ID: 36997325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Creation of Retinal Vein Occlusion Model in Cynomolgus Monkeys and Determination of its Pathological Features.
    Inagaki S; Shimazawa M; Otsu W; Araki T; Numata Y; Nakamura S; Tsusaki H; Hara H
    Curr Neurovasc Res; 2021; 18(1):123-133. PubMed ID: 32867658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Disorganization of Retinal Inner Layers With Visual Acuity Response to Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema Secondary to Retinal Vein Occlusion.
    Babiuch AS; Han M; Conti FF; Wai K; Silva FQ; Singh RP
    JAMA Ophthalmol; 2019 Jan; 137(1):38-46. PubMed ID: 30286219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The protective effect of anti-VEGF-A/Ang-2 bispecific antibody on retinal vein occlusion model mice.
    Kuriyama A; Nakamura S; Inokuchi Y; Abe H; Yasuda H; Hidaka Y; Nagaoka K; Soeda T; Shimazawa M; Hara H
    Eur J Pharmacol; 2024 Aug; 976():176691. PubMed ID: 38821166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Baseline Factors Associated With 6-Month Visual Acuity and Retinal Thickness Outcomes in Patients With Macular Edema Secondary to Central Retinal Vein Occlusion or Hemiretinal Vein Occlusion: SCORE2 Study Report 4.
    Scott IU; VanVeldhuisen PC; Ip MS; Blodi BA; Oden NL; King J; Antoszyk AN; Peters MA; Tolentino M;
    JAMA Ophthalmol; 2017 Jun; 135(6):639-649. PubMed ID: 28492860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral administration of NSP-116, a free radical scavenger, suppresses the symptoms of retinal vein occlusion in the murine model.
    Yamamoto T; Nitta K; Nishinaka A; Tanaka M; Nakamura S; Shimazawa M; Hara H
    Exp Eye Res; 2021 Mar; 204():108453. PubMed ID: 33503450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship Between Visual Acuity and Retinal Thickness During Anti-Vascular Endothelial Growth Factor Therapy for Retinal Diseases.
    Ou WC; Brown DM; Payne JF; Wykoff CC
    Am J Ophthalmol; 2017 Aug; 180():8-17. PubMed ID: 28549848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective study of aflibercept for the treatment of persistent macular oedema secondary to retinal vein occlusions in eyes not responsive to long-term treatment with bevacizumab or ranibizumab.
    Spooner K; Fraser-Bell S; Hong T; Chang A
    Clin Exp Ophthalmol; 2020 Jan; 48(1):53-60. PubMed ID: 31498950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Long-term outcomes of anti-VEGF therapy for macular edema in retinal vein occlusion].
    Drozdova EA
    Vestn Oftalmol; 2022; 138(3):140-148. PubMed ID: 35801893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathophysiological Role of VEGF on Retinal Edema and Nonperfused Areas in Mouse Eyes With Retinal Vein Occlusion.
    Nishinaka A; Inoue Y; Fuma S; Hida Y; Nakamura S; Shimazawa M; Hara H
    Invest Ophthalmol Vis Sci; 2018 Sep; 59(11):4701-4713. PubMed ID: 30267092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of non-exudative microcystoid macular abnormalities secondary to retinal vein occlusion.
    Francone A; Govetto A; Yun L; Essilfie J; Nouri-Mahdavi K; Sarraf D; Hubschman JP
    Graefes Arch Clin Exp Ophthalmol; 2021 Dec; 259(12):3579-3588. PubMed ID: 34155562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The correlation between cytokine levels in the aqueous humor and the prognostic value of anti-vascular endothelial growth factor therapy for treating macular edema resulting from retinal vein occlusion.
    Yong H; Qi H; Yan H; Wu Q; Zuo L
    Graefes Arch Clin Exp Ophthalmol; 2021 Nov; 259(11):3243-3250. PubMed ID: 34059950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effect of semaphorin 3A in the process of apoptosis in oxygen induced retinopathy in rats].
    Hua N; Liu H; Qian X; Dong L; Wu J; Li X
    Zhonghua Yan Ke Za Zhi; 2014 Jun; 50(6):440-7. PubMed ID: 25241977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reading speed improvements in retinal vein occlusion after ranibizumab treatment.
    Suñer IJ; Bressler NM; Varma R; Lee P; Dolan CM; Ward J; Colman S; Rubio RG
    JAMA Ophthalmol; 2013 Jul; 131(7):851-6. PubMed ID: 23699977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of Serum Inflammation-Based Factors in Anti-Vascular Endothelial Growth Factor Treatment for Macular Edema Secondary to Retinal Vein Occlusion and Its Subtypes.
    Rao J; Wu N; Qu X; Hu Y; Wu Y; Cheng Y; Yan L; Huang H; Li S; Shi L; Wu X
    Ophthalmic Res; 2021; 64(2):237-245. PubMed ID: 32506058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two or more dexamethasone intravitreal implants in treatment-naïve patients with macular edema due to retinal vein occlusion: subgroup analysis of a retrospective chart review study.
    Dugel PU; Capone A; Singer MA; Dreyer RF; Dodwell DG; Roth DB; Shi R; Walt JG; Scott LC; Hollander DA;
    BMC Ophthalmol; 2015 Sep; 15():118. PubMed ID: 26337664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of aqueous humor cytokines with the development of retinal ischemia and recurrent macular edema in retinal vein occlusion.
    Jung SH; Kim KA; Sohn SW; Yang SJ
    Invest Ophthalmol Vis Sci; 2014 Apr; 55(4):2290-6. PubMed ID: 24398091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sema3A Antibody BI-X Prevents Cell Permeability and Cytoskeletal Collapse in HRMECs and Increases Tip Cell Density in Mouse Oxygen-Induced Retinopathy.
    Zippel N; Kenny CH; Wu H; Garneau M; Kroe-Barrett R; Gupta P; Low S; Bakker RA; Thomas L
    Transl Vis Sci Technol; 2022 Jun; 11(6):17. PubMed ID: 35727188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.